Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET).
Caroline Petorin, Mathieu Baconnier, Delphine Poncet, Valérie Hervieu, Patricia Niccoli, Julien Hadoux, Vincent Hautefeuille, Rosine Guimbaud, Marine Perrier, Thomas Walter, Olivia Hentic, Christine Do Cao, Thierry Lecomte, Jean-Yves Scoazec, Thomas Aparicio, Benjamin Gibert, Maxime Bonjour, Léa Saban-Roche, Elisabeth Gaye, Marc Barritault, Laura Gerard, Alice Durand
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2025;43(8):960-971